RELATIONSHIP BETWEEN ELEVATION IN THE PLASMA-CONCENTRATION OF ELASTASE-ALPHA(1) PROTEINASE-INHIBITOR COMPLEX (E-ALPHA-1PI) AND HEMOSTATIC PARAMETERS DURING HEMODIALYSIS
M. Yamazaki et al., RELATIONSHIP BETWEEN ELEVATION IN THE PLASMA-CONCENTRATION OF ELASTASE-ALPHA(1) PROTEINASE-INHIBITOR COMPLEX (E-ALPHA-1PI) AND HEMOSTATIC PARAMETERS DURING HEMODIALYSIS, Blood coagulation & fibrinolysis, 6(1), 1995, pp. 5-10
To investigate the relationship between changes in plasma concentratio
ns of polymorphonuclear elastase (PMN-E) and haemostatic effects durin
g haemodialysis (HD), changes in the plasma concentrations of elastase
-alpha, proteinase inhibitor complex (E-alpha(1)PI) and fibrinogen (Fb
g), cross-linked fibrin degradation products (XDP), thrombin-antithrom
bin III complex (TAT), plasmin-alpha(2) plasmin inhibitor complex (PIG
) and soluble thrombomodulin (TM) in 49 patients with end-stage chroni
c glomerulonephritis maintained on chronic HD were measured. Plasma co
ncentrations of TAT, PIC, TM and E-alpha(1)PI significantly increased
during a single HD. There was a statistically significant correlation
between change in plasma E-alpha(1)PI concentration and changes in pla
sma concentrations of TAT, PIC and TM during a single HD, as well as b
etween changes in plasma concentrations of TM and TAT during a single
HD. These observations suggested that activation of coagulation and fi
brinolysis, endothelial cell damage, and activation of polymorphonucle
ar cells occur during HD. Activation of polymorphonuclear cells may in
duce activation of coagulation and fibrinolysis, leading to endothelia
l cell damage, augmented by release of proteases such as elastase.